Redefining resection margin status in pancreatic cancer
Caroline S. Verbeke,
Krishna V. Menon,
Corresponding Author
Caroline S. Verbeke
Departments of Histopathology and
Caroline S. Verbeke, Department of Histopathology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK. Tel: +44 113 2067802; Fax: +44 113 2067610; E-mail: [email protected]Search for more papers by this authorKrishna V. Menon
Surgery, St James's University Hospital, Leeds, UK
Search for more papers by this authorCaroline S. Verbeke,
Krishna V. Menon,
Corresponding Author
Caroline S. Verbeke
Departments of Histopathology and
Caroline S. Verbeke, Department of Histopathology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK. Tel: +44 113 2067802; Fax: +44 113 2067610; E-mail: [email protected]Search for more papers by this authorKrishna V. Menon
Surgery, St James's University Hospital, Leeds, UK
Search for more papers by this authorAbstract
Curative resection is crucial to survival in pancreatic cancer; however, despite optimization and standardization of surgical procedures, this is not always achieved. This review highlights that the rates of microscopic margin involvement (R1) vary markedly between studies and, although resection margin status is believed to be a key prognostic factor, the rates of margin involvement and local tumour recurrence or overall survival of pancreatic cancer patients are often incongruent. Recent studies indicate that the discrepancy between margin status and clinical outcome is caused by frequent underreporting of microscopic margin involvement. Lack of standardization of pathological examination, confusing nomenclature and controversy regarding the definition of microscopic margin involvement have resulted in the wide variation of reported R1 rates that precludes meaningful comparison of data and clinicopathological correlation.
References
- 1 Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G et al. (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54: 385–387.
- 2
Allema JH,
Reinders ME,
Van Gulik TM,
Koelemay MJ,
Van Leeuwen DJ,
De Wit LT et al. (1995) Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region.
Cancer
75: 2069–2076.
10.1002/1097-0142(19950415)75:8<2069::AID-CNCR2820750807>3.0.CO;2-7 PubMed Web of Science® Google Scholar
- 3 Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226: 248–260.
- 4 Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91: 586–594.
- 5 Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P et al. (2001) European Study Group for Pancreatic Cancer. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234: 758–768.
- 6 Matsuno S, Egawa S, Unno M. (2007) R0 resection for ductal pancreatic cancer – Japanese experience. Am J Surg 194: S110–S114.
- 7 Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217: 144–148.
- 8 Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221: 721–731.
- 9 Nitecki SS, Sarr MG, Colby TV, Van Heerden JA. (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221: 59–66.
- 10 Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. (1996) Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83: 625–631.
- 11 Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K et al. (1997) External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int J Radiat Oncol Biol Phys 39: 39–49.
- 12 Millikan KW, Deziel DJ, Silverstein JC, Kanjo TM, Christein JD, Doolas A et al. (1999) Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65: 618–623.
- 13 Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Mosella G. (2000) Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital 52: 263–270.
- 14 Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al. (2000) Resected adenocarcinoma of the pancreas – 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4: 567–579.
- 15 Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G et al. (2001) Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg 5: 121–130.
- 16 Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93: 1232–1237.
- 17 Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246: 52–60.
- 18 Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkbijl JHG, Bakkevold K et al. (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer. Meta-analysis of randomized controlled trials. Arch Surg 143: 75–83.
- 19 Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H et al. (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15: 1651–1600.
- 20 Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS. (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB 11: 18–24.
- 21 Verbeke CS. (2008) Resection margins and R1 rates in pancreatic cancer – are we there yet? Histopathology 52: 787–796.
- 22 Khalifa MA, Maksymov V, Rowsell C. (2009) Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist. Virchows Arch 454: 125–131.
- 23 Seiler CA, Wagner M, Sadowski C, Kulli C, Büchler MW. (2000) Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4: 443–452.
- 24 Zerbi A, Balzano G, Patuzzo R, Calori G, Braga M, Di Carlo V. (1995) Comparison between pylorus–preserving and Whipple pancreatoduodenectomy. Br J Surg 82: 975–979.
- 25 Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F et al. (1997) Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery 122: 553–566.
- 26 Diener MK, Heukäufer C, Schwarzer G, Seiler CM, Antes G, Büchler MW et al. (2008) Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev ( 2):CD006053.
- 27 Lin PW, Lin YJ. (1999) Prospective randomized comparison between pylorus-preserving and standard pancreatoduodenectomy. Br J Surg 86: 603–607.
- 28 Seiler C, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W et al. (2005) Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection – long term results. Br J Surg 92: 547–556.
- 29 Tran K, Smeenk H, Van Eijck C, Kazemier G, Hop W, Greve J et al. (2004) Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective randomized, multicenter analysis of 170 patients with pancreatic or periampullary tumors. Ann Surg 240: 738–745.
- 30 Pedrazzoli S, Beger HG, Obertop H, Andrén-Sandberg A, Fernández-Cruz L, Henne-Bruns D et al. (1999) A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 16: 337–345.
- 31 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236: 355–368.
- 32 Pedrazzoli P, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C et al. (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228: 508–517.
- 33 Farnell MB, Aranha GV, Nimura Y, Michelassi F. (2008) The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 12: 651–656.
- 34 Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptoleomos JP. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91: 1410–1427.
- 35 Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK et al. (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels. Perioperative outcome and long-term survival in 136 patients. Ann Surg 247: 300–309.
- 36 Westgaard A, Tafjord S, Farstand IN, Cvancarova M, Eide TJ, Mathisen O et al. (2008) Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 8: 5.
- 37 Khalifa MA, Maksymov V, Rowsell CH, Hanna S. (2007) A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. HPB 9: 146–149.
- 38 The Royal College of Pathologists (2002) Standards and Minimum Datasets for Reporting Cancers. Minimum Dataset for the Histopathological Reporting of Pancreatic, Ampulla of Vater and Bile Duct Carcinoma. London: The Royal College of Pathologists.
- 39 Japan Pancreas Society (2003) Classification of Pancreatic Cancer, 2nd English edn. Tokyo: Kanehara.
- 40
Greene FL,
Page DL,
Fleming ID,
Fritz AG,
Balch CM,
Haller DG. (2002) Exocrine pancreas. In: FL Greene,
DL Page,
ID Fleming, et al., eds.
AJCC Cancer Staging Manual, 6th
edn.
New York: Springer-Verlag, pp.
179–188.
10.1007/b97251_18 Google Scholar
- 41 Compton CC, Henson DE. (1997) Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 121: 1129–1136.
- 42 Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G. (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433: 237–242.
- 43 Albores-Saavedra J, Heffess C, Hruban RH, Klimstra D, Longnecker D. (1999) Recommendations for the reporting of pancreatic specimens containing malignant tumours. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 11: 304–307.
- 44 Chatelain D, Fléjou JF. (2002) Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports. Ann Pathol 22: 422–431.
- 45
Hruban RH,
Bishop Pitman M,
Klimstra DS. (2007) Tumors of the Pancreas. Atlas of tumor pathology, 4th Series, Fascicle 6. Washington, DC: Armed Forces Institute of Pathology.
10.55418/9781933477022 Google Scholar
- 46 Schwarz RE, Smith DD. (2006) Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13: 1189–1200.
- 47 Tomlinson JS, Jain S, Bentrem DJ, Sekeris EG, Maggard MA, Hines OJ et al. (2007) Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg 142: 1128–1137.
- 48 Ohigashi H, Ishikawa O, Sasaki Y, Yamada T, Furukawa H, Imaoka S et al. (2000) K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head. Arch Surg 135: 1450–1455.
- 49 Khalifa MA. (2007) Intraoperative assessment of the Whipple resection specimen. J Clin Pathol 60: 975–980.
- 50 Nagtegaal ID, Corrie A, Marijnen M, Klein Kranenbarg E, Van De Velde CJH, Van Krieken JHJM. (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimeter but two millimeters is the limit. Am J Surg Pathol 26: 350–357.
- 51 Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE et al. (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89: 327–334.
- 52 Verbeke CS, Menon KV, Knapp J. (2008) Tumour growth assessment using minimum spanning tree analysis in pancreatic, ampullary and distal bile duct cancer. HPB (Oxford) 10 (Suppl. 1): 61.
- 53 Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. (1991) Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21: 1137–1143.
- 54
Kayahara M,
Nagakawa T,
Ueno K,
Ohta T,
Takeda T,
Miyazaki I. (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging.
Cancer
72: 2118–2233.
10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar
- 55 Westerdahl J, Andren-Sandberg A, Ihse I. (1993) Recurrence of exocrine pancreatic cancer: local or hepatic? Hepatogastroenterology 40: 384–387.
- 56 Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Miyazaki I. (1997) Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 121: 611–617.
- 57 Chiche L, Alkoffer B, Parienti JJ, Rouleau V, Salamé E, Samama G et al. (2007) Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater. HPB (Oxford) 9: 140–145.
- 58 Park SW, Park YS, Chung JB, Kang JK, Kim KS, Choi JS et al. (2004) Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection. Hepatogastroenterology 51: 1612–1618.
- 59 De Castro SMM, Van Heek NT, Kuhlmann KFD, Busch OR, Offerhaus GJ, Van Gulik TM et al. (2004) Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery 136: 994–1002.
- 60 Scoggings CR, Lee JE, Evans DB. (2005) Pancreaticoduodenectomy with en bloc vascular resection and reconstruction for localized carcinoma of the pancreas. In: DD Von Hoff, DB. Evans RH Hruban, eds. Pancreatic Cancer. Sudbury, MA: Jones and Bartlett, pp. 321–334.
- 61 Yen T, Abdalla E, Pisters PWT, Evans DB. (2005) Pancreaticoduodenectomy. In: DD Von Hoff, DB Evans, RH Hruban, eds. Pancreatic Cancer. Sudbury, MA: Jones and Bartlett, pp. 265–285.
- 62 Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K et al. (1986) Collective review of small carcinomas of the pancreas. Ann Surg 203: 77–81.
- 63 Gomez D, Menon KV, Smith AM, Verbeke CS. (2008) Tumour location and number of positive lymph nodes are independent prognostic factors in distal bile duct cancer. HPB (Oxford) 10 (Suppl. 1): 227.
- 64 Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H et al. (2008) Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg: doi: 10.1016/j.amjsurg.2008.06.035.
Citing Literature
